Clinical Trials Logo

Clinical Trial Summary

This Is A Multicenter, Active-Controlled Trial To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects With Juvenile Idiopathic Arthritis


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00807846
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 4
Start date September 2009
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT00279747 - A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) Phase 3
Completed NCT00652925 - A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA Phase 3
Completed NCT02001844 - Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA N/A
Completed NCT00731965 - Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis Phase 4
Completed NCT02067962 - Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing N/A
Terminated NCT00868751 - Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis N/A
Terminated NCT00637780 - Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis Phase 4
Completed NCT00001614 - The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis Phase 1
Completed NCT01412021 - Special Investigation (All Case Survey) in Patients With Juvenile Idiopathic Arthritis
Enrolling by invitation NCT02377245 - Juvenile Inflammatory Rheumatism (JIR) Cohorte
Completed NCT00426218 - Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) Phase 1/Phase 2
Completed NCT00034853 - Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA) Phase 3
Completed NCT06000566 - Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis
Terminated NCT00511329 - Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease Phase 2/Phase 3
Terminated NCT00688545 - Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
Recruiting NCT00012506 - The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Phase 3